Skip to main content
 This program is not active.
On Demand

Suicide Prevention/Awareness


Total Credits: 1

Average Rating:
   28
State Associations:
TOMA - Texas
Faculty:
Brian Forsythe, DO
Duration:
53 Minutes
Expiration:
Never expires.


Description

This session will discuss the new DNA testing and new treatments for MDD and suicidal patients.

Objectives:

  1. Learn about new alternative treatment for MDD
  2. Become familiar with the new DNA testing to help with medication choices

Statement of Accreditation
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates is program for a maximum of 1 AOA Category 1-A credits and will report CME credits commensurate with the extent of the physician’s participation in this activity.

Grievance Policy
All grievances may be directed to TOMA's Executive Director at toma@txosteo.org. All grievances will receive an initial response within 30 days of receipt.  If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.

Handouts

Faculty

Brian Forsythe, DO Related Seminars and Products


Dr. Brian Forsythe is a board certified Doctor of Osteopathy.  He received his BS in Chemistry from Baylor University, his Doctor of Osteopathy from the University of North Texas Health Science Center and his degree in Psychiatry from the University of Texas at Southwestern. He has experience in inpatient psychiatric care and emergent psychiatric care.  Dr. Forsythe offers cutting edge treatments like Neurostar TMS Therapy, a non-systemic treatment for depression and GeneSightRx testing, a program that tailors medication treatments to the individual and offers clinicians insight to better understand how patients may metabolize or respond to medication prescribed to them. 

Dr. Forsythe discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.


Reviews

5
4
3
2
1

Overall:      4.2

Total Reviews: 28